coumarin has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
2H-chromen-2-one: coumarin derivative
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YH | 1 |
| Shin, EA | 1 |
| Jung, JH | 1 |
| Park, JE | 1 |
| Koo, J | 1 |
| Koo, JI | 1 |
| Shim, BS | 1 |
| Kim, SH | 1 |
| Lopez-Gonzalez, JS | 1 |
| Prado-Garcia, H | 1 |
| Aguilar-Cazares, D | 1 |
| Molina-Guarneros, JA | 1 |
| Morales-Fuentes, J | 1 |
| Mandoki, JJ | 1 |
| Marshall, ME | 1 |
| Mendelsohn, L | 1 |
| Butler, K | 1 |
| Cantrell, J | 1 |
| Harvey, J | 1 |
| Macdonald, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)[NCT00225537] | Phase 2 | 160 participants | Interventional | 2005-09-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for coumarin and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Non-Small-Cell Lung; Caspase 8; | 2019 |
Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines.
Topics: Adenocarcinoma; Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcin | 2004 |
Treatment of non-small cell lung cancer with coumarin and cimetidine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cimetid | 1987 |